Sclerostin antibody (Scl-Ab) improves osteomalacia phenotype in dentin matrix protein 1(Dmp1) knockout mice with little impact on serum levels of phosphorus and FGF23.
about
Osteocyte Protein Expression Is Altered in Low-Turnover Osteoporosis Caused by Mutations in WNT1 and PLS3.BMP1 and TLL1 Are Required for Maintaining Periodontal Homeostasis.Application of anti-Sclerostin therapy in non-osteoporosis disease models.Abnormally High and Heterogeneous Bone Matrix Mineralization After Childhood Solid Organ Transplantation: A Complex Pathology of Low Bone Turnover and Local Defects in Mineralization.Role of the Wnt/β-Catenin Pathway in Renal Osteodystrophy.
P2860
Sclerostin antibody (Scl-Ab) improves osteomalacia phenotype in dentin matrix protein 1(Dmp1) knockout mice with little impact on serum levels of phosphorus and FGF23.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Sclerostin antibody (Scl-Ab) i ...... evels of phosphorus and FGF23.
@en
type
label
Sclerostin antibody (Scl-Ab) i ...... evels of phosphorus and FGF23.
@en
prefLabel
Sclerostin antibody (Scl-Ab) i ...... evels of phosphorus and FGF23.
@en
P2093
P2860
P1433
P1476
Sclerostin antibody (Scl-Ab) i ...... levels of phosphorus and FGF23
@en
P2093
Baozhi Yuan
Jian Q Feng
Xianglong Han
P2860
P304
P356
10.1016/J.MATBIO.2015.12.009
P50
P577
2015-12-22T00:00:00Z